Trending News
News
News
New Insights Into Cognitive Disorders
A study of 35,000 people has revealed new genetic variations related to cognitive ability providing new hope for the treatment of cognitive disorders of the brain.
News
Brain-on-a-Chip Models Brain Connectivity
Researchers from Harvard University demonstrate the potential of the chip to model neurological and psychiatric diseases.
News
Neurodegeneration Linked To Concussion
Researchers provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in people genetically at risk of Alzheimer's Disease.
News
New Hope for Personalized Lung Cancer Treatment
Researchers have identified distinct tumor types within small cell lung cancer and a targeted drug combination that worked well against one of these specific tumor types.
News
Neurons Signal Spinal Cord Vascularisation
A study in zebrafish reveals neurons play an important role in signaling blood vessel growth.
News
Positive Allosteric Modulator Improves Neurodegenerative Outcomes
Global collaboration shows positive allosteric modulation of M1 Muscarinic receptors slows prion neurodegeneration and restores memory loss.
News
Deciding When Not To Act On Instinct
Scientists uncover neural connection that can prevent us acting on instinct.
News
Brain cell powerhouses appear good treatment target for stroke, TBI recovery
Cell powerhouses are typically long and lean, but with brain injury such as stroke or trauma, they can quickly become bloated and dysfunctional, say scientists who documented the phenomena in real time for the first time in a living brain.
News
Neural connection keeps instincts in check
Scientists identify the physical connection through which the prefrontal cortex inhibits instinctive behavior.
News
Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy
Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine aimed at this target works as a "booster" in conjunction with a drug called nusinersen that was recently ([US]) Food and Drug Administration- (FDA-) approved to improve symptoms of the disorder in mice.
Advertisement